V, S., DC, Z., G, L., A, A., E, K., H, G., & A, A. (2025). Bone mineral density changes following immune checkpoint inhibitor therapy: Insights from a case series analysis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 36(9), 1711. https://doi.org/10.1007/s00198-025-07647-2
Chicago Style (17th ed.) CitationV, Siampanopoulou, Ziogas DC, Lyrarakis G, Anastasopoulou A, Kassi E, Gogas H, and Angelousi A. "Bone Mineral Density Changes Following Immune Checkpoint Inhibitor Therapy: Insights from a Case Series Analysis." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 36, no. 9 (2025): 1711. https://doi.org/10.1007/s00198-025-07647-2.
MLA (9th ed.) CitationV, Siampanopoulou, et al. "Bone Mineral Density Changes Following Immune Checkpoint Inhibitor Therapy: Insights from a Case Series Analysis." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol. 36, no. 9, 2025, p. 1711, https://doi.org/10.1007/s00198-025-07647-2.